Immunocore Holdings plc (IMCR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.75B |
| Enterprise Value | 1.72B |
| P/E Ratio | -78.39 |
| PEG Ratio | 8.74 |
| Price/Sales Ratio | 3.87 |
| Price/Book Ratio | 3.78 |
| Enterprise/Revenue | 3.82 |
| Enterprise/EBITDA | 236.34 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.05 |
| Operating Margin | -0.08 |
| Return On Assets | -0.02 |
| Return On Equity | -0.05 |
| Revenue | 297.57M |
| Revenue/Share | 7.6 |
| Gross Profit | 291.36M |
| EBITDA | 387,177 |
| Net Income | -26.42M |
| Diluted EPS | -0.53 |
| Total Cash | 844.9M |
| Total Cash/Share | 16.65 |
| Total Debt | 435.68M |
| Total Debt/Equity | 1.11 |
| Current Ratio | 4.18 |
| Book Value Per Share | 7.76 |
| 52-Week Change | -5.69 |
| 52-Week High | 40.72 |
| 52-Week Low | 27.56 |
| Moving Average 50 Days | 29.3 |
| Moving Average 200 Days | 32.76 |
| Average Volume | 416,727 |
| Shares Outstanding | 50.83M |
| % Held by Institutions | 104.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |